Table 4. Neoadjuvant TRAEsa.
Patients (n=8) | Grade 1–2 | Grade 3 | Grade 4 |
---|---|---|---|
Anemia | 7 | – | – |
Neutropenia | 3 | 2 | 1 |
Thrombocytopenia | 3 | – | – |
Alopecia [grades 1, 2] | 7 [3, 4] | – | – |
Arthralgia | 2 | – | – |
Diarrhea | – | 1 | – |
Asthenia | 6 | 1 | – |
Nausea | 4 | 2 | – |
Pruritus | 4 | 1 | – |
Rash | 4 | – | – |
Peripheral neuritis | 2 | – | – |
Hypothyroidism | 2 | – | – |
Constipation | 2 | – | – |
a, TRAEs that occurred in more than two cases or > grade 2 were recorded here. Grade 1: alopecia <50%; grade 2: alopecia >50%. –, no. TRAEs, treatment-related adverse events.